Literature DB >> 30747012

CAR T-cells: costs, comparisons, and commentary.

Annette E Hay1,2, Matthew C Cheung2,3.   

Abstract

Mesh：

Year:  2019        PMID： 30747012     DOI： 10.1080/13696998.2019.1582059

Source DB:  PubMed          Journal:  J Med Econ        ISSN： 1369-6998            Impact factor:   2.448


× No keyword cloud information.
  14 in total

1.  Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel-treated patients in the TRANSCEND NHL 001 trial.

Authors:  Jeremy S Abramson; Tanya Siddiqi; Jacob Garcia; Christine Dehner; Yeonhee Kim; Andy Nguyen; Sophie Snyder; November McGarvey; Matthew Gitlin; Corey Pelletier; Monika P Jun
Journal:  Blood Adv       Date:  2021-03-23

Review 2.  Chimeric antigen receptor T-cell therapies: Optimising the dose.

Authors:  Nathaniel Dasyam; Philip George; Robert Weinkove
Journal:  Br J Clin Pharmacol       Date:  2020-03-24       Impact factor: 4.335

Review 3.  Biomaterials as Tools to Decode Immunity.

Authors:  Haleigh B Eppler; Christopher M Jewell
Journal:  Adv Mater       Date:  2019-11-29       Impact factor: 30.849

Review 4.  Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There?

Authors:  Norihiro Watanabe; Maksim Mamonkin
Journal:  Cancer J       Date:  2021 Mar-Apr 01       Impact factor: 3.360

Review 5.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 6.  CAR T cell therapy: newer approaches to counter resistance and cost.

Authors:  Rajesh Kumar Yadav; Asgar Ali; Santosh Kumar; Alpana Sharma; Basab Baghchi; Pritanjali Singh; Sushmita Das; Chandramani Singh; Sadhana Sharma
Journal:  Heliyon       Date:  2020-04-16

Review 7.  Challenges and Future Prospects of Precision Medicine in Psychiatry.

Authors:  Mirko Manchia; Claudia Pisanu; Alessio Squassina; Bernardo Carpiniello
Journal:  Pharmgenomics Pers Med       Date:  2020-04-23

Review 8.  NKp30 - A prospective target for new cancer immunotherapy strategies.

Authors:  Pedro F Pinheiro; Gonçalo C Justino; M Matilde Marques
Journal:  Br J Pharmacol       Date:  2020-08-26       Impact factor: 8.739

9.  Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy.

Authors:  Sasan Ghaffari; Monireh Torabi-Rahvar; Sajjad Aghayan; Zahra Jabbarpour; Kobra Moradzadeh; Azadeh Omidkhoda; Naser Ahmadbeigi
Journal:  BMC Immunol       Date:  2021-07-03       Impact factor: 3.615

Review 10.  Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.

Authors:  Alexander J Stephens; Nicola A Burgess-Brown; Shisong Jiang
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.